Technical Analysis for DARE - Dare Bioscience, Inc.

Grade Last Price % Change Price Change
grade C 0.84 1.20% 0.01
DARE closed up 1.2 percent on Wednesday, January 16, 2019, on 9 percent of normal volume. It was able to find support at its 50 day moving average. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Up Up
See historical DARE trend table...

Date Alert Name Type % Chg
Jan 16 50 DMA Support Bullish 0.00%
Jan 16 1,2,3 Pullback Bullish Bullish Swing Setup 0.00%
Jan 16 Boomer Buy Setup Bullish Swing Setup 0.00%
Jan 16 Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
Jan 16 Inside Day Range Contraction 0.00%
Jan 16 Wide Bands Range Expansion 0.00%
Jan 15 50 DMA Support Bullish 1.20%
Jan 15 1,2,3 Pullback Bullish Bullish Swing Setup 1.20%
Jan 15 Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 1.20%
Jan 15 Inside Day Range Contraction 1.20%

Older signals for DARE ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Dare Bioscience, Inc., formerly Cerulean Pharma Inc., is a healthcare company. The Company is focused on the development and commercialization of products in women’s reproductive health. Its lead product candidate is Ovaprene, a clinical stage, non-hormonal contraceptive ring. The Company is developing Ovaprene to provide protection over multiple weeks of use and require no intervention at the time of intercourse. Ovaprene has a custom intravaginal ring design, with a permeable mesh in the center of the ring that creates a partial barrier to sperm, and a mechanism to release locally acting spermiostatic agents through the ring. The combination of these two complementary approaches produces attractive contraceptive efficacy outcomes that are consistent with the effective barrier option, the diaphragm, and short-acting hormonal options, such as oral pill, patches and vaginal ring.
Is DARE a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 2 bullish, 1 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 3.59
52 Week Low 0.6
Average Volume 293,980
200-Day Moving Average 1.0261
50-Day Moving Average 0.8228
20-Day Moving Average 0.7505
10-Day Moving Average 0.8095
Average True Range 0.0847
ADX 37.38
+DI 25.9938
-DI 8.5914
Chandelier Exit (Long, 3 ATRs ) 0.6459
Chandelier Exit (Short, 3 ATRs ) 0.8541
Upper Bollinger Band 0.9013
Lower Bollinger Band 0.5997
Percent B (%b) 0.8
BandWidth 40.186542
MACD Line 0.0106
MACD Signal Line -0.0078
MACD Histogram 0.0184
Fundamentals Value
Market Cap 2.44 Million
Num Shares 2.9 Million
EPS -0.10
Price-to-Earnings (P/E) Ratio -8.40
Price-to-Sales 0.00
Price-to-Book 0.00
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.93
Resistance 3 (R3) 0.93 0.91 0.92
Resistance 2 (R2) 0.91 0.88 0.91 0.91
Resistance 1 (R1) 0.87 0.87 0.89 0.87 0.90
Pivot Point 0.85 0.85 0.86 0.85 0.85
Support 1 (S1) 0.81 0.82 0.83 0.81 0.78
Support 2 (S2) 0.79 0.81 0.79 0.77
Support 3 (S3) 0.75 0.79 0.77
Support 4 (S4) 0.75